
SAN FRANCISCO, CA – (February 24, 2021) – The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Clover Health Investments, Corp. (“Clover” or the “Company”) (NASDAQ: CLOV) between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”), including investors who purchased or otherwise acquired Clover securities pursuant or traceable to the Company’s registration statement and prospectus in connection with its merger with Social Capital Hedosophia Holdings Corp. III (“SCH”) in or around December 2020.